Flavonoid guide
Flavonoids

Naringin

Naringin is a citrus flavonoid abundant in grapefruit and other bitter citrus. Research documents antioxidant and metabolic effects in cells and animals, and a well-established ability to alter drug pharmacokinetics via intestinal enzymes and transporters.

Citrus naringin
Grapefruit flavonoid
Naringenin-7-O-rhamnoglucoside
Naringin hydrate

This guide covers all common forms and variations of naringin in one place. Use the sections below to find the form that fits your situation.

How it works in the body

Naringin is a glycosylated flavanone that is hydrolyzed by intestinal brush-border enzymes and gut microbiota to the aglycone naringenin. Naringenin is absorbed and undergoes phase II metabolism (glucuronidation and sulfation); plasma levels after naringin ingestion are dominated by these conjugates rather than the parent glycoside. In preclinical models, naringenin and its conjugates exert antioxidant effects via free-radical scavenging and modulate inflammatory and stress-response signaling—including inhibition of NF-κB and activation of Nrf2.

Separately, naringin and related grapefruit flavonoids inhibit intestinal cytochrome P450 3A4 (CYP3A4) and uptake transporters including OATP1A2 and OATP2B1. Inhibition of intestinal CYP3A4 reduces first-pass metabolism of susceptible drugs, increasing their systemic bioavailability. Inhibition of OATP transporters can reduce intestinal uptake of certain drugs. The direction and magnitude of these effects are drug-specific and underlie the clinically important grapefruit-drug interactions documented for many medications.

Naringin molecular structure
2D molecular structure from PubChem, National Library of Medicine.

Body systems

Gastrointestinal tract
Cardiovascular system
Liver/metabolism
Immune response

Associated molecules

Naringenin (aglycone)
Glucuronide conjugates
Sulfate conjugates

Track it lightly

If you plan to use naringin supplements or consume grapefruit regularly, track timing relative to medications and any new symptoms. Share those notes with your clinician before adjusting prescription dosing.

Trying this? Start tracking it here.

Background

Naringin was characterized as a major bitter flavonoid of grapefruit and related Citrus species during early 20th-century phytochemical research. Its name derives from historical Citrus nomenclature (Citrus naringia). By the late 20th century, naringin had drawn attention both for preclinical bioactive properties and for its central role in the grapefruit-drug interaction phenomenon, formally described in clinical pharmacology literature starting in the early 1990s.

Evidence snapshot

Laboratory and animal studies show that naringin and its aglycone naringenin have antioxidant, anti-inflammatory, and metabolic effects—modulating pathways such as NF-κB and Nrf2, improving lipid and glucose markers in rodent models, and affecting vascular function. Direct translation of these effects to humans remains unconfirmed.

Clinical evidence is mixed and often indirect. Human pharmacokinetic studies consistently demonstrate that grapefruit juice and isolated flavonoids including naringin inhibit intestinal CYP3A4 and organic anion transporting polypeptides (OATPs), causing clinically significant changes in plasma levels of many drugs. Human trials testing naringin supplements specifically for metabolic endpoints—lipids, blood pressure—are small and sparse.

Safety concerns center on interactions with medications metabolized or transported by intestinal CYP3A4 and OATPs (e.g., certain statins, calcium-channel blockers, immunosuppressants). Long-term safety data for high-dose naringin supplements in humans are absent; most safety guidance is extrapolated from the grapefruit-drug interaction literature and animal studies.

Bioavailability and metabolism

Naringin is poorly absorbed intact. Intestinal enzymes and gut bacteria hydrolyze it to naringenin, which is absorbed and conjugated to glucuronide and sulfate forms. Circulating levels reflect these conjugates rather than the parent glycoside. Interindividual variability in gut microbiota composition and phase II enzyme activity produces meaningful differences in naringenin exposure after equivalent naringin doses.

Populations studied

The large majority of efficacy data derives from in vitro cell studies and animal models. Human evidence is strongest for pharmacokinetic drug interactions using grapefruit juice or concentrated citrus extracts. Controlled clinical trials using isolated naringin for chronic disease endpoints (lipids, glucose, blood pressure) are sparse and generally small. Elderly patients and individuals on polypharmacy are the populations most frequently studied in the context of interaction risk.

Long-term safety

Long-term safety data for supplemental naringin in humans are absent. Safety guidance is extrapolated from the grapefruit-drug interaction literature. Some studies suggest that chronic high grapefruit juice intake produces persistent effects on intestinal CYP3A4 and transporter activity. High-dose long-term supplement use should be undertaken cautiously and with medical oversight when interacting medications are involved.

Analytical and product variation

Commercial naringin products vary in purity and actual naringin content. Some are standardized extracts; others are whole-fruit concentrates with variable composition. Naringin content in grapefruit juice varies by fruit variety, ripeness, processing, and storage, complicating dosing estimates and interaction risk prediction.

Compound variations

Naringenin (aglycone)

Naringin

The non-glycosylated form produced from naringin by gut enzymes; more readily absorbed and present in circulation primarily as glucuronide and sulfate conjugates.

Common use case

Research focusing on direct biological activity (antioxidant, metabolic pathways); free naringenin is not abundant in whole fruit.

Dosage note

Naringenin appears in circulation after naringin ingestion. Direct supplementation doses vary; human efficacy and safety data are limited.

Grapefruit juice (whole-food source)

Naringin

A dietary source of naringin and related flavonoids; concentrations vary by product and processing.

Common use case

Dietary flavonoid intake and culinary use; the most studied form in drug interaction research.

Dosage note

Typical study volumes range 200–500 mL; even a single 250–300 mL serving has produced measurable drug interaction effects.

Standardized naringin extract

Naringin

Concentrated extracts standardized to naringin content, used in supplements and some pharmacokinetic studies.

Common use case

Controlled dosing for research or supplementation; product quality varies between manufacturers.

Dosage note

Products commonly provide 100–500 mg naringin per serving. Confirm label content and consult a clinician if taking medications.

Citrus flavonoid blends (naringin + hesperidin, etc.)

Naringin

Multi-flavonoid supplements combining naringin with other citrus flavanones such as hesperidin; effects may differ from isolated naringin.

Common use case

Broad citrus flavonoid exposure; additive or altered interaction effects are possible.

Dosage note

Dosing reflects total flavonoid content; drug interaction risk persists and depends on the naringin fraction.

Dosage and best practices

Dosage principles

  • Most pharmacokinetic interaction studies used volumes of grapefruit juice (typically 200–500 mL) rather than isolated naringin. A single 250–300 mL glass of grapefruit juice has produced measurable CYP3A4 inhibition. Clinicians generally advise avoiding grapefruit juice within 24–72 hours of sensitive CYP3A4 substrate drugs.
  • Supplement labels commonly list naringin doses of 100–500 mg/day. No established clinical dose exists for metabolic endpoints; if used experimentally, the lower end of this range (100 mg/day) is a conservative starting point, with the caveat that long-term human safety data are lacking.
  • For drug-interaction risk: treat naringin exposure from juice or extracts the same as grapefruit—assume potential for significant interaction with CYP3A4 and OATP substrates, and discuss timing or avoidance with a prescriber before use.

Best practices

  • If you take prescription medications, check with your clinician or pharmacist before consuming grapefruit, grapefruit juice, or naringin supplements. Supplement form does not eliminate interaction risk.
  • Prefer whole-food citrus sources for dietary flavonoid intake. If using an extract, confirm the product's stated naringin content and start at a low dose.
  • Record the timing of naringin-containing foods or supplements relative to medication dosing and note any new symptoms (e.g., muscle pain, dizziness) to help identify potential interactions early.

Literature and references

Common questions

Will eating grapefruit or taking naringin supplements affect my prescription drugs?

Yes. Grapefruit and naringin-containing extracts inhibit intestinal CYP3A4 and certain uptake transporters, which can raise or unpredictably shift levels of many drugs. Check with your clinician or pharmacist before consuming grapefruit or naringin supplements if you take prescription medications.

Is naringin the same as naringenin?

No. Naringin is the glycoside (sugar-bound) form found in citrus fruit. Naringenin is the aglycone produced when naringin is hydrolyzed in the gut. Most biological effects measured in research are attributed to naringenin or its metabolites rather than intact naringin.

Can naringin lower cholesterol or blood pressure?

Animal models frequently show improvements in lipid and blood pressure markers, but high-quality human trials using isolated naringin are lacking. Any effect in humans is uncertain; do not substitute or reduce prescribed therapies based on current evidence.

How can I reduce interaction risk if I want to eat grapefruit?

The most reliable approach is to avoid grapefruit and grapefruit juice if you take drugs known to interact. If you choose to consume it, discuss the specific risk with your prescriber. Do not assume that spacing intake by a few hours eliminates risk—effects on intestinal enzymes can persist 24–72 hours after a single serving.

Related guides